Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)
Bangladesh · Delayed Price · Currency is BDT 70.00
-1.20 (-1.69%)
At close: Jul 26, 2026
Navana Pharmaceuticals Financials Overview
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Revenue Revenue Growth | 10,567 | 8,843 | 6,898 | 5,706 | 4,759 | 3,607 |
Revenue Growth | 24.76% | 28.19% | 20.89% | 19.91% | 31.95% | 14.53% |
Gross Profit Gross Profit Growth | 4,575 | 3,878 | 3,128 | 2,596 | 2,160 | 1,614 |
Operating Income Operating Income Growth | 1,492 | 1,446 | 991.84 | 755.72 | 569.6 | 348.59 |
Net Income Net Income Growth | 606.13 | 487.81 | 404.63 | 356.94 | 274 | 202.29 |
Earnings Per Share EPS Growth | 5.60 | 4.54 | 3.77 | 3.59 | 3.42 | 2.52 |
EPS Growth | 34.41% | 20.56% | 4.92% | 5.13% | 35.45% | 47.23% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Human Health Human Health Growth | 8,473 | 6,624 | 5,388 | 4,553 | 3,417 |
Veterinary Veterinary Growth | 1,640 | 1,404 | 1,270 | 1,030 | 711.69 |
Total Total Growth | 10,113 | 8,028 | 6,658 | 5,582 | 4,128 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Cash & Investments Cash & Investments Growth | 270.95 | 218.99 | 344.69 | 608.55 | 225.46 | 25.78 |
Total Debt Total Debt Growth | 3,919 | 4,649 | 5,377 | 4,329 | 3,012 | 1,491 |
Net Cash (Debt) Net Cash Growth | -3,648 | -4,430 | -5,032 | -3,721 | -2,786 | -1,466 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -33.71 | -41.24 | -46.85 | -37.42 | -34.73 | -18.27 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,375 | 1,815 | 707.3 | 193.74 | 199.36 | 121.75 |
Capital Expenditures CapEx Growth | -481.66 | -370.89 | -1,332 | -1,598 | -1,359 | -520.75 |
Free Cash Flow Free Cash Flow Growth | 1,894 | 1,444 | -625.1 | -1,404 | -1,160 | -399 |
Free Cash Flow Growth | 258.43% | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Gross Margin | 43.29% | 43.85% | 45.34% | 45.50% | 45.39% | 44.75% |
Operating Margin | 14.12% | 16.35% | 14.38% | 13.24% | 11.97% | 9.66% |
Pretax Margin | 7.67% | 7.49% | 7.48% | 7.87% | 8.23% | 8.39% |
Profit Margin | 5.74% | 5.52% | 5.87% | 6.25% | 5.76% | 5.61% |
FCF Margin | 17.92% | 16.33% | -9.06% | -24.61% | -24.37% | -11.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.400 | 1.400 | 1.400 | 1.300 | 1.100 |
Dividend Per Share Growth | 0% | 0% | 7.69% | 18.18% | - |
Dividend Yield | 1.97% | 2.86% | 1.69% | 1.19% | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 27, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 12.70 | 11.08 | 23.18 | 35.15 | - | - |
P/FCF Ratio | 4.04 | 3.74 | - | - | - | - |
PS Ratio | 0.72 | 0.61 | 1.36 | 2.20 | - | - |